Biltmore Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Biltmore Wealth Management's LLY Position: Q3 2026 in Review
Biltmore Wealth Management increased its Eli Lilly (LLY) stake by 0.29% in Q3 2026, buying an estimated $1.18K and bringing the position to 342 shares worth $396K. The position accounts for 0.12% of the portfolio, ranked #47.
Biltmore Wealth Management first reported a position in LLY in Q4 2014 and has held it in 15 quarters since. The position peaked at $410K in Q2 2026. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Biltmore Wealth Management held 342 shares of Eli Lilly worth $396K as of Q3 2026.
- Biltmore Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
- Eli Lilly made up 0.12% of Biltmore Wealth Management's portfolio in Q3 2026, its #47 holding.
- Biltmore Wealth Management first reported a position in Eli Lilly in Q4 2014 and has held it in 15 quarters since.
- Biltmore Wealth Management's Eli Lilly position peaked at $410K in Q2 2026.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Biltmore Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.